Interleukin-34 as a marker for subclinical proliferative lupus nephritis

Lupus. 2020 May;29(6):607-616. doi: 10.1177/0961203320914976. Epub 2020 Apr 1.

Authors

Asmaa Sm Abdel-Rehim¹, Nesrine A Mohamed², Marwa M Shakweer³

Affiliations

¹ Department of Internal Medicine, Allergy and Clinical Immunology, Faculty of Medicine, Ain Shams University, Cairo, Egypt.
² Department of Clinical Pathology and Immunology, Faculty of Medicine, Ain Shams University, Cairo, Egypt.
³ Department of Pathology, Faculty of Medicine, Ain Shams University, Cairo, Egypt.

PMID: 32237962
DOI: 10.1177/0961203320914976

No abstract available

Keywords: Lupus nephritis; serum IL-34; systemic lupus erythematosus.

Publication types

Observational Study

MeSH terms

Adult
Antibodies, Antinuclear / immunology
Biomarkers / metabolism*
Biopsy
Case-Control Studies
Cross-Sectional Studies
Egypt / epidemiology
Female
Humans
Interleukins / blood
Interleukins / metabolism*
Lupus Erythematosus, Systemic / complications*
Lupus Nephritis / blood*
Lupus Nephritis / diagnosis
Lupus Nephritis / pathology
Male
Severity of Illness Index

Substances

Antibodies, Antinuclear
Biomarkers
IL34 protein, human
Interleukins